The CDC greenlighted the Pfizer and Moderna COVID-19 vaccines for children younger than 5, following guidance from the FDA and the CDC’s Advisory Committee on Immunization Practices.
Parents with children in this category have waited months for such an announcement.
In November 2021, 5- to 11-year-olds became eligible for the vaccine through an Emergency Use Authorization (EUA). Then in February of this year, conversations about expanding that to younger children stalled, with the FDA citing a need for additional clinical trial data.
With the latest update, also by way of an EUA, anyone older than 6 months can now get a COVID-19 vaccine. Some have already received shots this week; the Biden Administration made some 10 million doses available immediately and says millions more will come soon.
To understand how this might play out, Penn Today spoke with Lori Handy, a physician in the Department of Pediatrics at the Perelman School of Medicine and medical director of infection prevention and control at the Children’s Hospital of Philadelphia.
Lori Handy is an assistant professor of clinical pediatrics in the Department of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania and medical director of infection prevention and control and an attending physician in the Division of Infectious Diseases at Children’s Hospital of Philadelphia.